missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Integrin beta 1/CD29 Antibody (12G10), Janelia Fluor™ 646, Novus Biologicals™
Mouse Monoclonal Antibody
Brand: Novus Biologicals NB100-63255JF646
This item is not returnable.
View return policy
Description
Integrin beta 1/CD29 Monoclonal specifically detects Integrin beta 1/CD29 in Human, Mustelid samples. It is validated for Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Frozen.
Specifications
| Integrinbeta1/CD29 | |
| Monoclonal | |
| Janelia Fluor 646 | |
| 50mM Sodium Borate with 0.05% Sodium Azide | |
| ITGB1 | |
| Purified human beta1 integrin preparation from HT1080 fibrosarcoma cell extract. | |
| 0.1 mL | |
| Primary | |
| NB100-63255 recognises the human beta1 integrin. This has been shown to bind to a ligand induced binding site, binding being increased in the presence of fibronectin ligand. This also enhances alpha 5 - beta 1 - fibronectin interactions. | |
| Store at 4°C in the dark. | |
| IgG1 |
| Flow Cytometry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry, Immunohistochemistry (Frozen) | |
| 12G10 | |
| Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Frozen | |
| CD29, CD29 antigen, Fibronectin receptor subunit beta, FNRBVLAB, GPIIA, integrin beta-1, integrin VLA-4 beta subunit, integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includesMDF2, MSK12), MDF2, MSK12, very late activation protein, beta polypeptide, VLA-4 subunit beta, VLA-BETA | |
| Mouse | |
| Protein G purified | |
| Cancer, Cytokine Research, Cytoskeleton Markers, Embryonic Stem Cell Markers, Immunology, Mesenchymal Stem Cell Markers, Neuronal Cell Markers, Neuronal Stem Cell Markers, Signal Transduction, Stem Cell Markers | |
| 3688 | |
| Human, Mustelid | |
| Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction